ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Novartis links with IBM for cancer care

by Marc S. Reisch
June 12, 2017 | APPEARED IN VOLUME 95, ISSUE 24

Novartis has signed what it says is a first-of-its-kind collaboration with IBM to optimize patient cancer care. The effort will link IBM’s Watson Health data cloud analytical capabilities with Novartis’s expertise in breast cancer treatment. Through the effort, the two hope to individualize treatment approaches and improve patient results. Teva Pharmaceuticals also uses the Watson cloud, and last year, it extended an agreement with IBM to search out new uses for existing drugs.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment